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Introduction
Although the manufacture of polychlorinated biphenyls (PCBs) has been legally banned in the US for over 30 years, they are persistent in the environment in large quantities and hazardous to public health (ASTDR, 2000; Robertson and Hansen, 2001 ). The originally released PCBs were predominantly highly chlorinated (6 or more chlorines per molecule).
However, PCBs in soils and marine sediments can be de-chlorinated to lower chlorinated congeners (Abramowicz, 1995; Master et al., 2002; ) . Lower chlorinated PCBs are semi-volatile and present in urban atmospheres of various areas in the U.S. and other countries (Wethington and Hornbuckle, 2005; Ruzickova et al., 2008) , and they move in dynamic balance among the atmosphere, water, and soil.
PCBs are biotransformed by cytochrome P450 (CYP) isoforms to hydroxylated PCBs (OHPCBs) (Kaminsky et al., 1981; Safe, 1994; McLean et al., 1996; Ludewig et al., 2007) .
Lower chlorinated PCBs are often more susceptible than highly chlorinated congeners to biotransformation in CYP-catalyzed reactions to OHPCBs. PCBs administered to rats are initially deposited in the liver and muscles, and then translocated to the skin and adipose tissue (Matthews and Anderson, 1975) . The OHPCBs, however, may be selectively concentrated in the liver as compared to adipose tissue, as indicated by a study where the concentration of OHPCBs was about 20 times higher in liver than that in adipose tissues, whereas the concentrations of total PCBs were not significantly different between the two tissues (Guvenius et al., 2002) . After CYP-catalyzed hydroxylation of PCBs, the resulting OHPCBs can be conjugated in reactions catalyzed by enzymes such as sulfotransferases (Liu et al., 2006; Wang et al., 2006) , UDPglucuronosyltransferases (Schnellmann et al., 1984; Tampal et al., 2002) , and glutathione Stransferases (James, 2001 ).
This article has not been copyedited and formatted. The final version may differ from this version. The sulfotransferases (SULTs) constitute a superfamily of biotransformation enzymes catalyzing the sulfation of a spectrum of substrates ranging from endogenous hormones and neurotransmitters to xenobiotics. OHPCBs have been observed to be inhibitors and substrates of human cytosolic sulfotransferases (hSULTs), e.g., hSULT1A1 (Wang et al., 2006) , hSULT1E1 (Kester et al., 2000) , and hSULT2A1 (Liu et al., 2006) , major family 1 and family 2 SULTs in humans. While hundreds of toxicological investigations on PCBs have been conducted utilizing rats or tissues/cells derived from rats, relatively little is known about the sulfation of OHPCBs in the rat. Moreover, the specificities of individual SULTs for OHPCBs in that species have not been extensively studied. This gap in our knowledge could potentially cause uncertainty in the extrapolation of studies from rat to human. We hypothesized that OHPCBs interact with rSULT1A1 (also previously known as aryl sulfotransferase IV) and rSULT2A3 (also previously known as sulfotransferase STa), two isoforms of SULT in the rat that are orthologous to human isoforms hSULT1A1 and hSULT2A1, respectively. rSULT1A1 is also of interest due to its ability to be regulated by the thiol:disulfide status of its environment (Marshall et al., 1997; Marshall et al., 2000; Duffel et al., 2001 ). There are five cysteine residues, located at positions 66, 82, 232, 283 , and 289 in each of the two identical subunits (homodimers) of rSULT1A1. It has been shown that the kinetics, specificity, and pH optima of rSULT1A1 are regulated by the oxidation status of Cys66 (i.e., conversion among the free thiol, a glutathione-protein mixed disulfide, and an intramolecular disulfide between Cys 66 and Cys232) (Marshall et al., 1997; Marshall et al., 2000) . These previous studies on rSULT1A1 led to our second hypothesis that interactions of OHPCBs with the purified rSULT1A1 and rSULT2A3 would be modified by changing the oxidative environment of the enzyme with oxidized glutathione. Although the sulfation of dehydroepiandrosterone (DHEA), a known DMD #26021 6 substrate of rSULT2A3, catalyzed by hepatic cytosol from male rats has been reported to be unaffected by treatment with oxidized glutathione (Maiti et al., 2004) , the potential for substratespecific modulation of a homogeneous preparation of rSULT2A3 by oxidized glutathione has not been investigated.
Thus, in the present study, 15 lower chlorinated congeners of OHPCBs, each bearing one hydroxyl (at the para-position for 14 and the ortho-position for 1 of the congeners) and 1-4 chlorine atoms in different substitution patterns, were investigated for their interaction with homogeneous recombinant rSULT1A1 and rSULT2A3 as substrates and inhibitors. The potential for alteration of the specificity of rSULT1A1 and rSULT2A3 for OHPCBs was explored by pretreatment of each enzyme with oxidized glutathione.
This article has not been copyedited and formatted. The final version may differ from this version. Table 1 ) has been reported previously (Lehmler and Robertson, 2001 ). In addition, three new OHPCBs were synthesized by Suzuki coupling of the corresponding chlorinated benzeneboronic acids and a suitable bromo chloro anisole, followed by demethylation with boron tribromide.
3,2'-Dichloro-biphenyl-4-ol (4'-OH PCB 6). White solid; mp=46-47°C (>99% by GC); 139.0, 132.9, 132.7, 131.4, 130.2, 130.1, 129.9, 128.9, 127.1, 119.7, 116.0 Adenosine 3'-phosphate 5'-phosphosulfate (PAPS) was obtained from Sigma-Aldrich (St. Louis, MO) and further purified by a published procedure (Sekura, 1981) to a purity greater This article has not been copyedited and formatted. The final version may differ from this version. (Chen et al., 1992) or rSULT2A3 were established using a pET-3c vector as previously described. Cells were grown, cell extract was prepared, and the enzymes were purified using minor modifications of a procedure developed for hSULT2A1 (Liu et al., 2006 (Duffel et al., 1989; ).
Inhibition of SULTs by OHPCBs.
Those OH-PCBs that were not substrates were investigated for potential inhibition of the sulfation of 2-naphthol (for rSULT1A1) and DHEA (for rSULT2A3). Reactions were conducted under non-saturating substrate concentrations (i.e., with 15 μ M 2-naphthol or 10 μ M DHEA). Each OHPCB was studied at various concentrations up to full inhibition of the reaction or the limit of solubility, as appropriate, and either 0.75 μ g rSULT1A1 or 0.5 μ g rSULT2A3 was used in each assay. Reactions were carried out at 37 °C for 6 min, and the sulfation rate was determined by substrate-dependent formation of PAP as described above.
Effect of oxidized glutathione on the specificities of SULTs for OHPCBs. For studies on the effect of disulfide on the SULTs, DTT was removed from the original enzyme preparations according to a previously reported method (Marshall et al., 1997) , with minor modifications. Briefly, either rSULT1A1 or rSULT2A3 in buffer B (0.5-1 mL) was added to a 5 ml PD-10 gel filtration column that had been equilibrated with buffer C (i.e., all components of buffer B except DTT). After elution with buffer C, the protein (3-5 mL) was concentrated to 0.5-1.0 mL by ultrafiltration using a 10-mL Amicon stirred cell with a PM-10 membrane. All manipulations were carried out at 4 °C. The resulting concentration of DTT was less than 0.06 mM as determined by a standard assay for thiols employing 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) (Jocelyn, 1987) .
Stock solutions of reduced and oxidized glutathione (10 mM) were prepared in buffer C, and the pH was adjusted with potassium hydroxide to 7.5. Each enzyme:glutathione mixture was prepared in a 9:1 ratio (v:v), such that the final concentration of either reduced or oxidized glutathione was 1 mM and there was a 10% decrease in protein concentration. Each enzyme in argon-saturated buffer C containing either 1 mM reduced glutathione (GSH) or 1 mM oxidized glutathione (GSSG) was incubated at 25°C for 1 h. Aliquots of these solutions of enzymes were then used in the assay of sulfation reactions as described above, but without addition of any additional reducing agents to the assay mixtures (i.e., 2-mercaptoethanol was absent from the reaction mixtures). Reaction mixtures contained 0.25 M potassium phosphate at pH 7.0, 200 μ M PAPS, the OHPCB at either 100 μ M or a lower concentration if its limit of solubility was less This article has not been copyedited and formatted. The final version may differ from this version. were carried out for each treatment. Reaction mixtures were incubated at 37 °C for 6 min (rSULT1A1) and 15 min (rSULT2A3), respectively. An assay containing all components except OHPCB was utilized to determine the OHPCB-dependent formation of PAP with either the reduced or oxidized enzyme. These control experiments in the absence of any OHPCB exhibited less than 18 μM PAP (rSULT1A1) and 13 μM PAP (rSULT2A3) formed in the course of the assay period, and these controls were subtracted from the PAP formed in the presence of
OHPCBs to determine the rate of substrate-dependent formation of PAP. For those OHPCBs that were observed to be substrates for oxidized rSULT1A1, multiple concentrations of OHPCBs were then utilized under the same conditions as described above. Two substrates for reduced rSULT1A1, 4'-OH PCB 9 and 6'-OH PCB 35 (representing kinetic profiles both with and without substrate inhibition, respectively) were also examined for differences in sulfation catalyzed by GSH-and GSSG-pretreated rSULT1A1. After each preincubation of enzyme with GSH at 25 °C for 1 h, an aliquot of the mixture was analyzed with DTNB (Jocelyn, 1987) for thiol content in order to determine the stability of the reduced glutathione under the experimental conditions.
Reversibility of the effect of GSSG on SULT1A1 by reduction. After removal of reducing agents by PD-10 chromatography, rSULT1A1 was pretreated with either 5 mM DTT or 1 mM GSSG at 25°C for 1 hr as described above. The resulting enzyme preparations were utilized to determine substrate-dependent formation of PAP with either 2-naphthol (250 μM) or 4'-OH PCB 6 (200 μM). An aliquot of 1 mM GSSG-pretreated rSULT1A1 was further treated This article has not been copyedited and formatted. The final version may differ from this version. with 5 mM DTT (incubation at 25°C for 1 h) to reduce disulfide bonds in the enzyme, and the rate of sulfation of either 2-naphthol or 4'-OH PCB 6 was then determined.
Solubility of OHPCBs in the SULT assays. The solubility of each OHPCB was determined at 37°C in 0.25 M potassium phosphate at pH 7.0 containing 3.3% (v/v) acetone and 7.5 mM 2-mercaptoethanol. The previously described use of light scattering at 400 nm (Blomquist et al., 1978; Liu et al., 2006) was employed using a Perkin-Elmer LS-55
Luminescence Spectrometer.
This article has not been copyedited and formatted. The final version may differ from this version. Structure-activity analysis of OHPCBs with rSULT1A1. As shown in Fig. 2A -C, the most potent inhibitors of rSULT1A1 have a 3,5 dichloro-4-hydroxy substitution pattern. For example, a 6-fold difference in IC 50 is observed with the addition of a 5'-chlorine atom to 4'-OH PCB 25 (i.e., 4'-OH PCB 68). The presence or absence of a chlorine atom at the 4-position of the non-phenolic ring has a small effect on the magnitude of the IC 50 value observed ( Fig. 2A and   2C ). However, a change in chlorine atoms between the 2 and 3 positions on the aromatic ring bearing a 4-OH group (Fig. 2D ) results in large changes in the interactions with rSULT1A1, as is also the case when chlorine atoms at the 2' and 3' positions (on the non-phenolic ring) are altered in a 3-chloro-4-OH PCB (Fig. 2E) . Thus, there appears to be a significant role of chlorine atoms in the 2 (or 2') and 3 (or 3') positions of 4'-OH PCBs in determining their ability to serve as substrates and inhibitors of rSULT1A1.
Effects of pretreatment of rSULT1A1 and rSULT2A3 with oxidized and reduced glutathione on their abilities to catalyze sulfation of OHPCBs. The nine OHPCBs that were not substrates for either SULT under the assay conditions used for experiments in Table 1, were further examined for their potential to serve as substrates following treatment of the enzymes with oxidized and reduced glutathione. In order to examine the response of these enzymes to the thiol:disulfide ratio in their environment, the DTT present during purification was removed by gel filtration chromatography, and the enzymes were incubated for one hour at 25°C under argon in the presence of either 1 mM GSH or 1 mM GSSG as described in Materials and
Methods. At the end of the incubation of the enzyme with 1 mM GSH, the concentration of Table 1 . None of these nine OHPCBs were substrates for the rSULT1A1 that had been pretreated with 1 mM GSH, a result similar to that obtained under standard assay conditions where the enzyme was in a buffer containing DTT and 2-mercaptoethanol was present in the reaction mixtures (as described above). However, with rSULT1A1 that had been pretreated with 1 mM GSSG, four of the OHPCBs became substrates for the enzyme with the following rates of sulfation (expressed in nmoles product/min/mg protein; n=3): 4'-OH PCB 6 (43.2 ± 9.6) , 4-OH PCB 14 (23.2 ± 2.1), 4'-OH PCB 33 (12.1 ± 7.2), and 4'-OH PCB 36 (9.7 ± 1.6). The rSULT2A3 that had been pretreated with either GSH or GSSG did not catalyze sulfation of any of the nine OHPCBs.
Two of the OHPCBs that were substrates for rSULT1A1 under reducing conditions, 4'-OH PCB 9 and 6'-OH PCB 35, were used to investigate the potential modulation of their sulfation by oxidation of rSULT1A1. As shown in Fig. 3A , sulfation of both OHPCBs catalyzed by GSSG-pretreated rSULT1A1 was only slightly increased when compared to that seen with GSH-pretreated enzyme. Furthermore, the absence of substrate inhibition with 6'-OH PCB 35
and the presence of substrate inhibition with 4'-OH PCB 9, were seen in both reduced and oxidized rSULT1A1-catalyzed reactions. enzyme with 1 mM GSSG. Three of these compounds, namely 4'-OH PCB 6, 4-OH PCB 14 and 4'-OH PCB 33, showed concentration-dependent sulfation (Fig. 3B) , whereas 4'-OH PCB 36 showed sulfation only at its limit of solubility, 50 μ M. The sulfation of the three OHPCBs catalyzed by oxidized rSULT1A1 demonstrated a kinetic profile significantly different from that observed with most of the OHPCBs that were substrates for reduced rSULT1A1.
Reversibility of oxidized rSULT1A1 in its ability to catalyze sulfation of 4'-OH PCB 6
As shown in Table 2 , the sulfation of 2-naphthol catalyzed by rSULT1A1 was slightly enhanced by pretreatment of the enzyme with 1 mM GSSG compared to that with 1 mM GSH (p<0.05). This effect was similar to that observed for the rates of sulfation of 4'-OH PCB 9 and 6'-OH PCB 35 catalyzed by oxidized versus reduced rSULT1A1. Upon reducing the oxidized rSULT1A1 by subsequent treatment with 5 mM DTT, the catalytic activity with 2-naphthol as substrate was reduced to the original level as catalyzed by the enzyme pretreated with only DTT.
For 4'-OH PCB 6, pretreatment of rSULT1A1 with 5 mM DTT or 1mM GSSG led to a more significant difference in its catalytic activity. Under reducing conditions, 4'-OH PCB 6 was not a substrate for rSULT1A1, but after pretreatment of the enzyme with 1 mM GSSG, the rate of sulfation was 37.3 ± 4.0 nmoles of product/mg/min. After reduction of the oxidized enzyme with 5 mM DTT, it no longer catalyzed the sulfation of 4'-OH PCB 6. Thus, the effects of altering the thiol:disulfide environment of rSULT1A1 were fully reversible for 4'-OH PCB 6.
This article has not been copyedited and formatted. The final version may differ from this version. hydroxylation has primarily occurred at the para-, and, with a lower frequency, at the metapositions (Bergman et al., 1994; Sandau et al., 2000) . Studies on rats exposed to PCBs have resulted in similar findings; i.e., 4(4')-hydroxylated and 3(3')-hydroxylated PCBs were the main metabolites (Chen et al., 1976; Schnellmann et al., 1984; Haraguchi et al., 2004) . It is particularly interesting that the concentrations of these OHPCB metabolites in blood may, in some cases, be higher than the parent PCBs, with additional selective concentration of OHPCBs in liver and other tissues (Bergman et al., 1994) . For example, one of 13 OHPCBs detected in rat plasma following a dose of Aroclor 1254 was 4-OH-2,3,5,3',4'-pentachlorobiphenyl, and this OHPCB was observed at concentrations of 0.7-1.8 ng/mg lipid in the liver at various time points (Bergman et al., 1994) . Our calculations suggest that this is approximately equivalent to a concentration range of 0.1 -0.3 μM. Although caution is necessary in comparisons between concentrations of OHPCBs calculated based on tissue lipid content and concentrations utilized with the purified enzyme, a reasonable conclusion is that the tissue concentrations likely to be seen for the OHPCBs examined in our current study would be unlikely to have significant effects on the catalytic activity of rSULT2A3. Thus, our results indicate that the major family 2 SULT in rat liver differs significantly from the major family 2 SULT in human liver, hSULT2A1, in its interactions with OHPCBs. For example, our recent studies indicate that 4-OH PCB 34 and 4'-OH PCB 68 are good substrates for hSULT2A1, and 4'-OH PCB 9 is a potent inhibitor of hSULT2A1 (Liu et al., 2006) .
This article has not been copyedited and formatted. The final version may differ from this version. In contrast to rSULT2A3, the major hepatic family 1 SULT in the rat, rSULT1A1, had significant interactions with OHPCBs. For those OHPCBs that were substrates for rSULT1A1, the rate of product formation would depend directly on the concentration of the OHPCB, since they would likely be present at non-saturating concentrations. Some inhibitory OHPCBs, particularly those with IC 50 values in the sub-micromolar range, may be candidates for examination of in vivo inhibition of rSULT1A1.
These results with rSULT1A1 can be compared with a previous report on human SULT1A1 (Wang et al., 2006) , where 18 OHPCBs were found to inhibit the sulfation of 4-nitrophenol catalyzed by recombinant hSULT1A1 and by human liver cytosol, and at least three of these also served as substrates. Several OHPCBs used in that study were also included in our experiments, and there are similarities in the interactions of these OHPCBs with human and rat SULT1A1. However, there are also some notable differences. Unlike rSULT1A1 which was most potently inhibited by OHPCBs bearing the 3,5-dichloro-4-hydroxy substitution pattern (e.g., 4-OH PCB 14, 4-OH PCB 34, and 4-OH PCB 36), OHPCBs with a 3,5-dichloro-4-hydroxy substitution pattern showed slightly weaker inhibition of hSULT1A1 than 3-chloro-4-hydroxy substituted PCBs (Wang et al., 2005) . In this regard, the rSULT1A1 is more similar to hSULT1E1 (human estrogen sulfotransferase), where the 3,5-dichloro-4-hydroxy substitution pattern in OHPCBs provided the most potent inhibition of hSULT1E1 (Kester et al., 2000) .
Taken together, the above findings with OHPCBs indicate that the major hepatic family 2 SULTs in the rat and human (rSULT2A3 and hSULT2A1, respectively) are distinctly different in their interactions with OHPCBs, while the interactions of OHPCBs with rSULT1A1 have more similarities to the human family 1 SULTs than differences. It should be noted that this does not necessarily mean that all family 2 SULTs in the rat do not interact strongly with OHPCBs, as the recent studies on placental transfer of PCBs and OHPCBs in humans (Park, et al., 2008) show that
OHPCBs are more efficiently transferred than the parent PCBs. This increased placental transfer to the fetus was proposed to be due to higher protein-binding of OHPCBs as opposed to the greater lipid distribution of the parent PCBs (Park, et al., 2008) . Further elaboration of differences in the transport and tissue concentrations of OHPCBs will undoubtedly facilitate analysis of potential in vivo interactions with SULTs.
The kinetic characteristics of various OHPCBs as substrates for rSULT1A1 under standard assay (reduced) conditions demonstrated significant variations, with most showing substrate inhibition.
The kinetic data for OHPCBs with substrate inhibition, however, were not described well by a simple Michaelis-Menten model. 4-Nitrophenol, a prototype substrate for rSULT1A1 that has been extensively studied, displays pronounced substrate inhibition in reactions catalyzed by reduced rSULT1A1, and this has been classified as a form of uncompetitive substrate inhibition (Marshall et al., 2000) . The underlying mechanism for this kinetic behavior is due to the formation of a dead end ternary complex: E-PAP-ROH (where E is the rSULT1A1, PAP is the reaction product derived from PAPS, and ROH is a phenolic substrate) (Marshall et al., 2000) . The binary complex of PAP bound to reduced rSULT1A1 (i.e., E-PAP) is relatively stable, and the binding of different phenolic
This article has not been copyedited and formatted. The final version may differ from this version. substrates (e.g., 4-nitrophenol, OHPCBs, and others) to E-PAP may have differential effects on the stability of the inhibitory ternary complex (Marshall et al., 2000; Duffel et al., 2001 ).
Compared to reduced rSULT1A1, oxidized rSULT1A1 exhibits profoundly altered kinetic interactions with its substrates. As exemplified with 4-nitrophenol and 2-naphthol, changes in pH optima (from 5.2 to 6.3 and 5.4 to 7.2, respectively), and disappearance of substrate inhibition have been observed upon oxidation of rSULT1A1 with GSSG (Marshall et al., 1997; Marshall et al., 1998; Marshall et al., 2000) . Additional changes in substrate specificity were seen upon oxidation of the enzyme with GSSG (Marshall et al., 2000) . Upon treatment of rSULT1A1 with GSSG in the present study, we observed the conversion of four of the nine inhibitory OHPCBs to substrates. The underlying structural modification responsible for the altered kinetic behavior upon treatment of rSULT1A1 with GSSG for short time periods has been shown to be the formation of a glutathioneprotein mixed disulfide at Cys66 followed by the formation of an intramolecular disulfide between Cys66 and Cys232 (Marshall et al., 1997) . As rSULT1A1 is oxidized further, e.g., treatment with 1 mM GSSG at 25 °C for more than 1 h, additional cysteines form disulfide bonds and the specific activity of the enzyme is decreased; after treatment for 12-24 h, all five cysteines are oxidized, and the enzyme is completely inactivated (Marshall et al., 1997; Marshall et al., 2000) . Homology modeling studies indicate that oxidation of Cys66 and Cys232 affects the conformation of the protein in the vicinity of the PAPS/PAP binding site, and therefore changes the dissociation of the E-PAP-ROH dead-end complex ). Thus, under oxidative conditions, the ternary complex E-PAP-ROH may undergo nucleotide exchange with PAPS and the catalytic cycle can proceed (Marshall et al., 2000) . As noted in the previous studies on the mechanism of rSULT1A1 under reduced and oxidized conditions, the changes due to initial disulfide formation are reversible (Marshall et al., 1997; Marshall et al., 2000) . Indeed, our results also indicated that GSSGThis article has not been copyedited and formatted. The final version may differ from this version. dependent changes in the kinetic behavior of rSULT1A1 with 4'-OH PCB 6 were reversible by reduction with DTT ( Table 2) .
As described in the original studies on the effect of oxidation on mechanism of the enzyme (Marshall et al., 1997; Marshall et al., 2000) , these effects of partial oxidation of cysteines in rSULT1A1 suggest an important regulatory mechanism whereby the specificity and kinetics of the enzyme can be altered by oxidative stress. This is particularly intriguing in the case of the OHPCBs examined in the current study, since, for some OHPCBs, cellular oxidative stress may determine whether the molecule inhibits rSULT1A1 or is sulfated in a reaction catalyzed by the enzyme. In addition to oxidative stress created by disease states or exposure to other xenobiotics, recent work on the potential role of quinone metabolites of PCBs and their involvement in creation of oxidative stress within cells Srinivasan et al., 2002) suggests that, by inducing oxidative stress, some OHPCBs may influence sulfation of other OHPCBs or interfere with other sulfation reactions. Finally, the recent report of disulfide-mediated regulation of hSULT1E1 (Maiti et al., 2007) and the presence of cysteine residues homologous to Cys66 in other SULTs suggest that the substrate-dependent nature of the effects seen with the OHPCBs in our current results may also be seen in the redox regulation of other SULTs.
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